The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.

Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

The US FDA has granted 510(k) clearance for Exactech’s Equinoxe Scapula Reconstruction System for acromial and scapular spine fractures.

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.